No black box warning on record for Milrinone Lactate

As of the latest FDA labeling reviewed, Milrinone Lactate (MILRINONE LACTATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Milrinone Lactate medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Whether given orally or by continuous or intermittent intravenous infusion, milrinone lactate has not been shown to be safe or effective in the longer (greater than 48 hours) treatment of patients with heart failure. In a multicenter trial of 1088 patients with Class III and IV heart failure, long-term oral treatment with milrinone lactate was associated with no improvement in symptoms an

No black box warning on record for Milrinone Lactate

Other warnings & precautions

WARNINGS Whether given orally or by continuous or intermittent intravenous infusion, milrinone lactate has not been shown to be safe or effective in the longer (greater than 48 hours) treatment of patients with heart failure. In a multicenter trial of 1088 patients with Class III and IV heart failure, long-term oral treatment with milrinone lactate was associated with no improvement in symptoms an

Milrinone Lactate Black Box Warning

No black box warning on record for Milrinone Lactate

Other warnings & precautions

Milrinone Lactate Black Box Warning

No black box warning on record for Milrinone Lactate

Other warnings & precautions